WO2012104874A3 - Aqueous concentrated formulation of linezolid - Google Patents
Aqueous concentrated formulation of linezolid Download PDFInfo
- Publication number
- WO2012104874A3 WO2012104874A3 PCT/IN2012/000080 IN2012000080W WO2012104874A3 WO 2012104874 A3 WO2012104874 A3 WO 2012104874A3 IN 2012000080 W IN2012000080 W IN 2012000080W WO 2012104874 A3 WO2012104874 A3 WO 2012104874A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- linezolid
- aqueous concentrated
- concentrated formulation
- formulation
- aqueous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Disclosed is the aqueous concentrated formulation of linezolid, more particularly, the aqueous concentrated formulation of linezolid comprising at least one solubilizer, wherein the formulation is preferably administered intravenously.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN307/CHE/2011 | 2011-02-02 | ||
IN307CH2011 | 2011-02-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012104874A2 WO2012104874A2 (en) | 2012-08-09 |
WO2012104874A3 true WO2012104874A3 (en) | 2012-11-01 |
Family
ID=46603173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2012/000080 WO2012104874A2 (en) | 2011-02-02 | 2012-02-02 | Aqueous concentrated formulation of linezolid |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012104874A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104173949B (en) * | 2014-09-12 | 2017-04-05 | 大理药业股份有限公司 | A kind of XINGNAOJING ZHUSHEYE and preparation method thereof |
CN106491528B (en) * | 2016-12-02 | 2019-09-24 | 江苏豪森药业集团有限公司 | Linezolid Injection and preparation method thereof |
CN111920772A (en) * | 2020-09-04 | 2020-11-13 | 浙江普利药业有限公司 | Linezolid dry suspension and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130379A (en) * | 1993-09-09 | 1996-09-04 | 厄普约翰公司 | Substituted oxazine and thiazine oxazolidinone antimicrobials |
WO2002030395A1 (en) * | 2000-10-10 | 2002-04-18 | Pharmacia & Upjohn Company | Topical antibiotic composition for treatment of eye infection |
CN1713924A (en) * | 2000-08-22 | 2005-12-28 | 法马西亚公司 | Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading |
CN101948442A (en) * | 2009-07-10 | 2011-01-19 | 符健 | Preparation method of linezolid and preparation thereof |
-
2012
- 2012-02-02 WO PCT/IN2012/000080 patent/WO2012104874A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130379A (en) * | 1993-09-09 | 1996-09-04 | 厄普约翰公司 | Substituted oxazine and thiazine oxazolidinone antimicrobials |
CN1713924A (en) * | 2000-08-22 | 2005-12-28 | 法马西亚公司 | Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading |
WO2002030395A1 (en) * | 2000-10-10 | 2002-04-18 | Pharmacia & Upjohn Company | Topical antibiotic composition for treatment of eye infection |
CN101948442A (en) * | 2009-07-10 | 2011-01-19 | 符健 | Preparation method of linezolid and preparation thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2012104874A2 (en) | 2012-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016016666A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2016015093A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2015008627A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
NI201500135A (en) | PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE | |
MX361499B (en) | Deuterated baricitinib. | |
IT1404931B1 (en) | OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES. | |
PH12015500900A1 (en) | A stabilized pemetrexed formulation | |
TW201144301A (en) | Processes for preparing linezolid | |
BR112014025041B8 (en) | PHARMACEUTICAL COMPOSITION | |
WO2012116010A3 (en) | Antibiotic tolerance inhibitors | |
CA2873723A1 (en) | Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase | |
WO2013003669A3 (en) | Compositions, methods of use, and methods of treatment | |
EP3034082A4 (en) | Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients | |
UA115357C2 (en) | Pyridin-4-yl derivatives | |
TWD161614S (en) | Bottle | |
WO2011079193A3 (en) | Preparation of bendamustine and its salts | |
MX347373B (en) | Stable anti-inflammatory solutions for injection. | |
CL2014003123A1 (en) | 5-amino [1,4], thiazines as bace1 inhibitors; use of the compound against Alzheimer's disease. | |
WO2014160281A3 (en) | Method of enhancing delivery of therapeutic compounds to the eye | |
WO2015173427A3 (en) | Rapid-acting insulin composition comprising a substituted anionic compound and a polyanionic compound | |
IL232194A (en) | Cross-linking composition deliverd by inotophoresis, useful for the treatment of keratoconus | |
WO2012104874A3 (en) | Aqueous concentrated formulation of linezolid | |
WO2014155389A3 (en) | Process for preparation of ticagrelor | |
EP2864328B8 (en) | Pharmaceutically active compounds | |
EP3064501A4 (en) | 2-methylsulphanyl-6-nitro-7-oxo-1, 2, 4-triazolo [5, 1-c][1, 2, 4]triazinide l-arginine dihydrate active toward west nile virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12741785 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12741785 Country of ref document: EP Kind code of ref document: A2 |